StockData
Fennec Pharmaceuticals Inc. logo

Fennec Pharmaceuticals Inc. (FENC) stock

FENCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3088% above fair value
$13.33−0.25 (-1.84%)

Close on Nov 18, 2026Market cap $467.45MP/E –Yield –

Fennec Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Fennec Pharmaceuticals's revenue for the twelve months ending Jun 30, 2026 was $59.22M, up 77.8% year over year. For fiscal 2025 it was $44.64M, down 6.1% from the year before. The highest annual figure on record is $47.54M in fiscal 2024.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$44.64M-6.1%
FY2024Dec 31, 2024$47.54M+123.7%
FY2023Dec 31, 2023$21.25M+1284.5%
FY2022Dec 31, 2022$1.54M+667.5%
FY2020Dec 31, 2020$200.00K–
FY2019Dec 31, 2019$0–
FY2018Dec 31, 2018$0–
FY2017Dec 31, 2017$0–
FY2016Dec 31, 2016$0–
FY2015Dec 31, 2015$0–
FY2014Dec 31, 2014$0–
FY2013Dec 31, 2013$0–
FY2012Dec 31, 2012$0–
FY2011Dec 31, 2011$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$17.87M+85.2%
Q1 FY2026Mar 31, 2026$15.11M+72.6%
Q4 FY2025Dec 31, 2025$13.78M+73.8%
Q3 FY2025Sep 30, 2025$12.46M+78.7%
Q2 FY2025Jun 30, 2025$9.65M+32.9%
Q1 FY2025Mar 31, 2025$8.75M-65.5%
Q4 FY2024Dec 31, 2024$7.93M-18.6%
Q3 FY2024Sep 30, 2024$6.97M+7.0%
Q2 FY2024Jun 30, 2024$7.26M+118.4%
Q1 FY2024Mar 31, 2024$25.38M+1413.2%
Q4 FY2023Dec 31, 2023$9.74M–
Q3 FY2023Sep 30, 2023$6.52M+3157.5%
Q2 FY2023Jun 30, 2023$3.33M–
Q1 FY2023Mar 31, 2023$1.68M–
Q1 FY2021Mar 31, 2021$0–
Q4 FY2020Dec 31, 2020$200.00K–
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$0–
Q1 FY2020Mar 31, 2020$0–
Q4 FY2019Dec 31, 2019$0–
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$0–
Q1 FY2019Mar 31, 2019$0–
Q4 FY2018Dec 31, 2018$0–
Q3 FY2018Sep 30, 2018$0–
Q2 FY2018Jun 30, 2018$0–
Q1 FY2018Mar 31, 2018$0–
Q4 FY2017Dec 31, 2017$0–
Q3 FY2017Sep 30, 2017$0–
Q2 FY2017Jun 30, 2017$0–
Q1 FY2017Mar 31, 2017$0–
Q4 FY2016Dec 31, 2016$0–
Q3 FY2016Sep 30, 2016$0–

More Fennec Pharmaceuticals figures

See a number that looks wrong?